What are MiNENs?
Mixed Neuroendocrine–Non-Neuroendocrine Neoplasms, commonly known as MiNENs, are rare hybrid tumours that contain two different types of cancer cells within the same tumour. One component is neuroendocrine, and the other is non-neuroendocrine, usually adenocarcinoma or squamous carcinoma.
According to the World Health Organization (WHO), each component must make up at least 30 percent of the tumour to be classified as MiNEN.
These tumours most commonly occur in the gastrointestinal tract, including the stomach, colon, pancreas, and esophagus.
Incidence
MiNENs are rare and represent a small percentage of gastrointestinal cancers. They usually affect adults and are more commonly diagnosed in middle-aged or older individuals.
Because they contain mixed components, they may initially be misdiagnosed as a single tumour type unless thorough pathological examination is performed.
Symptoms
The symptoms of MiNENs mainly depend on where the tumour is located in the digestive system. When the tumour develops in the stomach, a person may feel persistent upper abdominal discomfort, burning pain, early fullness after eating a small amount of food, nausea, or vomiting.
Sometimes there may be slow internal bleeding from the tumour, which can lead to weakness, tiredness, pale skin, and anemia. If the bleeding is more obvious, the patient may notice black-colored stools or even vomiting of blood in severe cases.
When the tumour is present in the colon, symptoms may include ongoing abdominal pain, bloating, constipation, diarrhoea, or alternating bowel habits. Some patients notice blood mixed in the stool or experience unexplained weight loss. There may also be a feeling that the bowel does not empty completely. Over time, chronic blood loss can again cause anemia, leading to fatigue and shortness of breath on exertion.
If the tumour arises in the pancreas, symptoms are often different. A tumour in the head of the pancreas may block the bile duct, leading to jaundice, which causes yellowing of the skin and eyes, dark urine, pale stools, and itching. Patients may also experience upper abdominal pain that spreads to the back, poor appetite, nausea, indigestion, and unintended weight loss.
Overall, these symptoms are not very specific and can look similar to those seen in common gastrointestinal cancers. Because of this, proper medical evaluation, imaging, and biopsy are necessary to make an accurate diagnosis.
Diagnosis
Diagnosis begins with imaging studies such as CT scan or endoscopy. A biopsy is required for confirmation.
Microscopic examination reveals two distinct components: a neuroendocrine part and a non-neuroendocrine carcinoma part. Immunohistochemical staining helps confirm neuroendocrine differentiation.
Accurate diagnosis is important because treatment decisions depend on identifying both tumour components.
Treatment
Treatment is challenging and depends on the most aggressive component of the tumour. Surgery is usually performed when the disease is localised.
If the neuroendocrine component is high-grade and aggressive, chemotherapy protocols used for neuroendocrine carcinomas may be applied. In some cases, treatment strategies are combined to address both tumour types.
Prognosis
The prognosis depends largely on the grade and stage of the most aggressive component. High-grade neuroendocrine components are associated with poorer outcomes.
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways: